Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Anxiety and Depression in Cancer Patients
NCT00465595Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2007
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in anxiety disorder, major depressive disorder (MDD), sponsored by Johns Hopkins University. Started Apr 2007; status: completed.
02
Drugs
psilocybin
03
Conditions
anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00465595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00465595.